Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Nephrology - Original Paper

The association of glomerular filtration rate and erectile dysfunction with severity of coronary artery disease in patients presenting with chest pain

Authors: Yalcin Solak, Hakan Akilli, Huseyin Atalay, Mehmet Kayrak, Hasan Gok, Suleyman Turk

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

Background

The most common cause of death in patients with chronic kidney disease is cardiovascular. Coexistence of reduced estimated glomerular filtration rate (eGFR) and erectile dysfunction (ED) may predate severe underlying coronary artery disease (CAD). The aim of this study was to evaluate the predictive value of presence and severity of ED and reduced estimated eGFR in the risk stratification of CAD in patients with chest pain.

Methods

Two hundred and sixty-five consecutive male patients with chest pain were included. All patients underwent exercise stress test (EST), of whom those with positive EST underwent coronary angiography. eGFR was calculated and sexual health inventory for men (SHIM) form was applied to evaluate ED. The relation between SHIM scores, eGFR and the number of arteries with significant lesions was evaluated.

Results

Of the 265 male patients, 105 had positive EST while the remaining 160 patients had negative EST. ED was present in 62 patients (38.8%) in the EST (−) group and in 64 patients (61%) in the EST (+) group (P = 0.000). In the EST (+) group, coronary angiography (CAG) revealed normal coronary anatomy or insignificant coronary lesions in 19 (18%), one-vessel disease in 45 (43%), two-vessel disease in 22 (21%) and three-vessel disease in 19 (18%) patients, respectively. The lowest ED prevalence (36.8%) was seen in patients who had normal coronary anatomy or insignificant coronary lesions while the highest prevalence was in those with three-vessel disease (89.5%). When eGFR were taken into account, there was a significant difference between the groups as well (107.2 ± 19.2 ml/min in the EST (−) group versus 94.1 ± 20.0 ml/min in the EST (+) group; P = 0.001).

Conclusion

The presence and severity of ED and reduced eGFR are associated with the severity of underlying CAD in patients presenting with chest pain, and they could be implemented in the risk stratification of these patients.
Literature
1.
go back to reference Padma-Nathan H (2000) Diagnostic and treatment strategies for erectile dysfunction: the ‘Process of Care’ model. Int J Impot Res 4:119–121CrossRef Padma-Nathan H (2000) Diagnostic and treatment strategies for erectile dysfunction: the ‘Process of Care’ model. Int J Impot Res 4:119–121CrossRef
2.
go back to reference Lee JH, Ngengwe R, Jones P et al (2008) Erectile dysfunction as a coronary artery disease risk equivalent. J Nucl Cardiol 15:800–803PubMed Lee JH, Ngengwe R, Jones P et al (2008) Erectile dysfunction as a coronary artery disease risk equivalent. J Nucl Cardiol 15:800–803PubMed
3.
go back to reference Kloner RA (2008) Erectile dysfunction as a predictor of cardiovascular disease. Int J Impot Res 20:460–465CrossRefPubMed Kloner RA (2008) Erectile dysfunction as a predictor of cardiovascular disease. Int J Impot Res 20:460–465CrossRefPubMed
4.
go back to reference Turk S, Karalezli G, Tonbul HZ et al (2001) Erectile dysfunction and effects of sildenafil treatment in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 16:1818–1822CrossRefPubMed Turk S, Karalezli G, Tonbul HZ et al (2001) Erectile dysfunction and effects of sildenafil treatment in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 16:1818–1822CrossRefPubMed
5.
go back to reference Türk S, Guney I, Altintepe L et al (2004) Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract 96:21–27CrossRef Türk S, Guney I, Altintepe L et al (2004) Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract 96:21–27CrossRef
6.
go back to reference Costa C, Virag R (2009) The endothelial-erectile dysfunction connection: an essential update. J Sex Med 6(9):2390–2404 Costa C, Virag R (2009) The endothelial-erectile dysfunction connection: an essential update. J Sex Med 6(9):2390–2404
7.
go back to reference Gazzaruso C, Pujia A, Solerte SB et al (2006) Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res 18:311–315CrossRefPubMed Gazzaruso C, Pujia A, Solerte SB et al (2006) Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res 18:311–315CrossRefPubMed
8.
go back to reference Yaman O, Gulpinar O, Hasan T et al (2008) Erectile dysfunction may predict coronary artery disease: relationship between coronary artery calcium scoring and erectile dysfunction severity. Int Urol Nephrol 40:117–123CrossRefPubMed Yaman O, Gulpinar O, Hasan T et al (2008) Erectile dysfunction may predict coronary artery disease: relationship between coronary artery calcium scoring and erectile dysfunction severity. Int Urol Nephrol 40:117–123CrossRefPubMed
9.
go back to reference Tokgoz H, Yaman O, Gulec S et al (2008) Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group. Int Urol Nephrol 40:373–376CrossRefPubMed Tokgoz H, Yaman O, Gulec S et al (2008) Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group. Int Urol Nephrol 40:373–376CrossRefPubMed
10.
go back to reference Pecoits-Filho R, Heimbürger O, Ba’ra’ny P et al (2003) Associations between circulating inflammatory markers and residual renal function in ESRD patients. Am J Kidney Dis 41:1212–1218CrossRefPubMed Pecoits-Filho R, Heimbürger O, Ba’ra’ny P et al (2003) Associations between circulating inflammatory markers and residual renal function in ESRD patients. Am J Kidney Dis 41:1212–1218CrossRefPubMed
11.
go back to reference Montorsi F, Briganti A, Salonia A et al (2003) Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44:360–365CrossRefPubMed Montorsi F, Briganti A, Salonia A et al (2003) Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44:360–365CrossRefPubMed
12.
go back to reference Rosen RC, Cappelleri JC, Smith MD et al (1999) Development and evaluation of an abridged 5-item version of international index of erectile function (IIEF) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326CrossRefPubMed Rosen RC, Cappelleri JC, Smith MD et al (1999) Development and evaluation of an abridged 5-item version of international index of erectile function (IIEF) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326CrossRefPubMed
13.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute. National high blood pressure education program coordinating committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute. National high blood pressure education program coordinating committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252
14.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed
15.
go back to reference Jarow JP, Kloner RA, Holmes AM (1998) Viagra. M. Evans and Company, Inc. New York Jarow JP, Kloner RA, Holmes AM (1998) Viagra. M. Evans and Company, Inc. New York
16.
go back to reference Kaiser DR, Billups K, Mason C et al (2004) Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43:179–184CrossRefPubMed Kaiser DR, Billups K, Mason C et al (2004) Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43:179–184CrossRefPubMed
17.
18.
go back to reference Billups K, Bank A, Padma-Nathan H et al (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2:40–52CrossRefPubMed Billups K, Bank A, Padma-Nathan H et al (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2:40–52CrossRefPubMed
19.
go back to reference Greenstein A, Chen J, Miller H et al (1997) Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 9:123–126CrossRefPubMed Greenstein A, Chen J, Miller H et al (1997) Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 9:123–126CrossRefPubMed
20.
go back to reference Montorsi P, Ravagnani PM, Galli S et al (2006) Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 27:2632–2639CrossRefPubMed Montorsi P, Ravagnani PM, Galli S et al (2006) Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 27:2632–2639CrossRefPubMed
22.
go back to reference Cottone S (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179PubMed Cottone S (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179PubMed
23.
go back to reference Bellinghien G, Santoro D, Mallamace A et al (2008) Sexual dysfunction in chronic renal failure. J Nephrol 21(suppl. 13):113–117 Bellinghien G, Santoro D, Mallamace A et al (2008) Sexual dysfunction in chronic renal failure. J Nephrol 21(suppl. 13):113–117
24.
go back to reference Messina LE, Claroj A, Nardozza A et al (2007) Erectile dysfunction in patients with chronic renal failure. Int Braz J Urol 33:673–678PubMed Messina LE, Claroj A, Nardozza A et al (2007) Erectile dysfunction in patients with chronic renal failure. Int Braz J Urol 33:673–678PubMed
25.
Metadata
Title
The association of glomerular filtration rate and erectile dysfunction with severity of coronary artery disease in patients presenting with chest pain
Authors
Yalcin Solak
Hakan Akilli
Huseyin Atalay
Mehmet Kayrak
Hasan Gok
Suleyman Turk
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9694-y

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue

Urology - Original Paper

Urethral stricture Yemen experience

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.